International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

…, N Gangat, U Gianelli, LA Godley… - Blood, The Journal …, 2022 - ashpublications.org
The classification of myeloid neoplasms and acute leukemias was last updated in 2016
within a collaboration between the World Health Organization (WHO), the Society for …

[PDF][PDF] Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

…, E Paietta, B Löwenberg, JD Licht, LA Godley… - Cancer cell, 2010 - cell.com
Cancer-associated IDH mutations are characterized by neomorphic enzyme activity and
resultant 2-hydroxyglutarate (2HG) production. Mutational and epigenetic profiling of a large …

[PDF][PDF] Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation

…, M Beran, J Zavadil, SD Nimer, A Melnick, LA Godley… - Cancer cell, 2011 - cell.com
Somatic loss-of-function mutations in the ten-eleven translocation 2 (TET2) gene occur in a
significant proportion of patients with myeloid malignancies. Although there are extensive …

Dnmt3a is essential for hematopoietic stem cell differentiation

…, Y Lu, GJ Darlington, A Meissner, JPJ Issa, LA Godley… - Nature …, 2012 - nature.com
Loss of the de novo DNA methyltransferases Dnmt3a and Dnmt3b in embryonic stem cells
obstructs differentiation; however, the role of these enzymes in somatic stem cells is largely …

Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine

…, L Zhang, TJ Looney, B Zhang, LA Godley… - Nature …, 2011 - nature.com
In contrast to 5-methylcytosine (5-mC), which has been studied extensively 1 , 2 , 3 , little is
known about 5-hydroxymethylcytosine (5-hmC), a recently identified epigenetic modification …

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

…, BL Ebert, P Fenaux, LA Godley… - Blood, The Journal …, 2022 - ashpublications.org
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for
diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized …

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

…, M Gonen, CE Mason, A Melnick, LA Godley… - Nature …, 2012 - nature.com
Aging is characterized by clonal expansion of myeloid-biased hematopoietic stem cells and
by increased risk of myeloid malignancies. Exome sequencing of three elderly females with …

5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging

…, AI Levey, A Vasanthakumar, LA Godley… - Nature …, 2011 - nature.com
DNA methylation dynamics influence brain function and are altered in neurological
disorders. 5-hydroxymethylcytosine (5-hmC), a DNA base that is derived from 5-methylcytosine, …

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

…, MS Tallman, G Meloni, LA Godley… - Blood, The Journal …, 2011 - ashpublications.org
In a randomized trial of therapy for FMS-like tyrosine kinase-3 (FLT3) mutant acute myeloid
leukemia in first relapse, 224 patients received chemotherapy alone or followed by 80 mg of …

[PDF][PDF] Inherited and somatic defects in DDX41 in myeloid neoplasms

…, N Nguyen, S Mukherjee, C Pabst, LA Godley… - Cancer cell, 2015 - cell.com
Most cases of adult myeloid neoplasms are routinely assumed to be sporadic. Here, we
describe an adult familial acute myeloid leukemia (AML) syndrome caused by germline …